Comparison of Enteric-Coated Mycophenolate Sodium With Mycophenolate Mofetil in Living Renal Allograft Transplantation

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2041-2043

  Minz, M ^a   Sharma, A ^a   Heer, M ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD TOXICITY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENTERIC COATED TABLET; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL;

ADULT; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; REPRODUCIBILITY OF RESULTS; TABLETS, ENTERIC-COATED;

EID: 33846105370     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.07.011     Document Type: Article

References (5)

1. European Mycophenolate Mofetil Study Group. Placebo controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroid for prevention of acute rejection. Lancet 345 (1995) 1321
2. The Tricontinental MMF Renal Transplantation Study Group. A blinded, randomized clinical trial of MMF for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61 (1996) 1029
3. Pelletier R.P., Akin B., Henry M.L., et al. Mycophenolate mofetil dose reduction influences clinical outcome following kidney transplantation. Clin Transplant 17 (2003) 200
4. Salvadori M., Holzer H., de Mattos A., et al. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 4 (2004) 231
5. Budde K., Curtis J., Knoll G., et al. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients. Am J Transplant 4 (2004) 237